BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

691 related articles for article (PubMed ID: 32345778)

  • 21. LncRNA XIST regulates atherosclerosis progression in ox-LDL-induced HUVECs.
    Gao H; Guo Z
    Open Med (Wars); 2021; 16(1):117-127. PubMed ID: 33542956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circ_0000345 Protects Endothelial Cells From Oxidized Low-Density Lipoprotein-Induced Injury by miR-129-5p/Ten-Eleven Translocation Axis.
    Tiliwaldi H; Tursun A; Tohti A; Mamatzunun M; Wu Z
    J Cardiovasc Pharmacol; 2021 May; 77(5):603-613. PubMed ID: 33951697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA PVT1 knockdown alleviated ox-LDL-induced vascular endothelial cell injury and atherosclerosis by miR-153-3p/GRB2 axis via ERK/p38 pathway.
    Guo J; Li J; Zhang J; Guo X; Liu H; Li P; Zhang Y; Lin C; Fan Z
    Nutr Metab Cardiovasc Dis; 2021 Nov; 31(12):3508-3521. PubMed ID: 34627697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Notoginsenoside R1 upregulates miR-221-3p expression to alleviate ox-LDL-induced apoptosis, inflammation, and oxidative stress by inhibiting the TLR4/NF-κB pathway in HUVECs.
    Zhu L; Gong X; Gong J; Xuan Y; Fu T; Ni S; Xu L; Ji N
    Braz J Med Biol Res; 2020; 53(6):e9346. PubMed ID: 32401923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circ_USP36 Silencing Attenuates Oxidized Low-Density Lipoprotein-Induced Dysfunction in Endothelial Cells in Atherosclerosis Through Mediating miR-197-3p/ROBO1 Axis.
    Zhang Y; Li W; Li H; Zhou M; Zhang J; Fu Y; Zhang C; Sun X
    J Cardiovasc Pharmacol; 2021 Nov; 78(5):e761-e772. PubMed ID: 34369900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA OIP5-AS1 accelerates ox-LDL-treated HUVECs injury by NF-κB pathway via miR-30c-5p.
    Zhang L; Li Q; Chen Y; Zhu Q
    Clin Hemorheol Microcirc; 2021; 78(4):449-460. PubMed ID: 33867356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silence of long intergenic noncoding RNA HOTAIR ameliorates oxidative stress and inflammation response in ox-LDL-treated human macrophages by upregulating miR-330-5p.
    Liu J; Huang GQ; Ke ZP
    J Cell Physiol; 2019 Apr; 234(4):5134-5142. PubMed ID: 30187491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CircIRAK1 aggravates ox-LDL-induced endothelial cell injury in atherosclerosis via TRIM14 upregulation by binding to miR-330-5p.
    Liu F; Gao B; Wang Y
    Clin Hemorheol Microcirc; 2023; 85(3):195-209. PubMed ID: 36336926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circular RNA Circ-BANP Regulates Oxidized Low-density Lipoprotein-induced Endothelial Cell Injury Through Targeting the miR-370/Thioredoxin-interacting Protein Axis.
    Chen G; Li Y; Zhang A; Gao L
    J Cardiovasc Pharmacol; 2021 Mar; 77(3):349-359. PubMed ID: 33298736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of circ_0003204 alleviates oxidative low-density lipoprotein-induced human umbilical vein endothelial cells injury: Circulating RNAs could explain atherosclerosis disease progression.
    Su Q; Dong X; Tang C; Wei X; Hao Y; Wu J
    Open Med (Wars); 2021; 16(1):558-569. PubMed ID: 33869778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidized Low Density Lipoprotein-Induced Atherogenic Response of Human Umbilical Vascular Endothelial Cells (HUVECs) was Protected by Atorvastatin by Regulating miR-26a-5p/Phosphatase and Tensin Homolog (PTEN).
    Jia Z; An L; Lu Y; Xu C; Wang S; Wang J; Teng X
    Med Sci Monit; 2019 Dec; 25():9836-9843. PubMed ID: 31865360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resveratrol protects against ox-LDL-induced endothelial dysfunction in atherosclerosis via depending on circ_0091822/miR-106b-5p-mediated upregulation of TLR4.
    Chen J; Liu Y; Liu Y; Peng J
    Immunopharmacol Immunotoxicol; 2022 Dec; 44(6):915-924. PubMed ID: 35736860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circ-USP9X Inhibition Reduces Oxidized Low-density Lipoprotein-induced Endothelial Cell Injury via the microRNA 599/Chloride Intracellular Channel 4 Axis.
    Peng H; Sun J; Li Y; Zhang Y; Zhong Y
    J Cardiovasc Pharmacol; 2021 Oct; 78(4):560-571. PubMed ID: 34269702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-217-5p ameliorates endothelial cell apoptosis induced by ox-LDL by targeting CLIC4.
    Zhang X; Wang Z; Li W; Huang R; Zheng D; Bi G
    Nutr Metab Cardiovasc Dis; 2020 Mar; 30(3):523-533. PubMed ID: 31744714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paeonol suppresses the effect of ox-LDL on mice vascular endothelial cells by regulating miR-338-3p/TET2 axis in atherosclerosis.
    Yu Y; Yan R; Chen X; Sun T; Yan J
    Mol Cell Biochem; 2020 Dec; 475(1-2):127-135. PubMed ID: 32770325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myricetin ameliorates ox-LDL-induced HUVECs apoptosis and inflammation via lncRNA GAS5 upregulating the expression of miR-29a-3p.
    Bai Y; Liu X; Chen Q; Chen T; Jiang N; Guo Z
    Sci Rep; 2021 Oct; 11(1):19637. PubMed ID: 34608195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LNCRNA OIP5-AS1 regulates oxidative low-density lipoprotein-mediated endothelial cell injury via miR-320a/LOX1 axis.
    Zhang C; Yang H; Li Y; Huo P; Ma P
    Mol Cell Biochem; 2020 Apr; 467(1-2):15-25. PubMed ID: 32072428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA MIAT Mediates ox-LDL-Induced Endothelial Cell Injury Via miR-206/RAB22A Axis.
    Gao Y; Yue J; Huang Z
    J Surg Res; 2021 Sep; 265():303-312. PubMed ID: 33965771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of Circular Ubiquitin-specific Peptidase 9 X-Linked Alleviates Oxidized Low-density Lipoprotein-induced Injuries of Human Umbilical Vein Endothelial Cells by Mediating the miR-148b-3p/KLF5 Signaling Pathway.
    Jiang X; Chen L; Wu H; Chen Y; Lu W; Lu K
    J Cardiovasc Pharmacol; 2021 Dec; 78(6):809-818. PubMed ID: 34882112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CircCHMP5 Contributes to Ox-LDL-induced Endothelial Cell Injury Through the Regulation of MiR-532-5p/ROCK2 axis.
    Li X; Kang X; Di Y; Sun S; Yang L; Wang B; Ji Z
    Cardiovasc Drugs Ther; 2023 Dec; 37(6):1-12. PubMed ID: 35084579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.